Linked Life Data

20347123

Source:http://linkedlifedata.com/resource/pubmed/id/20347123

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-5-14
pubmed:abstractText
Disseminated gynecologic cancers are usually fatal due to chemoresistance. Recently, rationally developed, targeted agents are entering the early clinical trials setting. We assessed patients with metastatic gynecologic cancers in a dedicated phase I clinical trials clinic in order to determine their outcome.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-12324630, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-12903007, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-15745980, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-15745986, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-16341064, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-16434629, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-16716801, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-17471559, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-17617530, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-17878745, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-18268546, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-18336403, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-18349816, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-18569027, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-18657909, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-18694380, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19029210, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19055724, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19064964, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19078924, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19097774, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19165805, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19169045, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19190080, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19234438, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19332246, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19332248, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19332249, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19332251, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19430562, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19461667, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19471664, http://linkedlifedata.com/resource/pubmed/commentcorrection/20347123-19485991
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1095-6859
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
467-72
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.
pubmed:affiliation
Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. john.moroney@wpafb.af.mil
pubmed:publicationType
Journal Article, Clinical Trial, Phase I, Research Support, N.I.H., Extramural